• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Nov 22;11(1):22666.
doi: 10.1038/s41598-021-01215-4.
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19


Mattia Bellan[SUP] 1 2 3 [/SUP], Alessio Baricich[SUP] 4 5 [/SUP], Filippo Patrucco[SUP] 4 5 [/SUP], Patrizia Zeppegno[SUP] 4 5 [/SUP], Carla Gramaglia[SUP] 4 5 [/SUP], Piero Emilio Balbo[SUP] 5 [/SUP], Alessandro Carriero[SUP] 4 5 [/SUP], Chiara Santa Amico[SUP] 4 [/SUP], Gian Carlo Avanzi[SUP] 4 5 [/SUP], Michela Barini[SUP] 5 [/SUP], Marco Battaglia[SUP] 4 5 [/SUP], Simone Bor[SUP] 4 5 [/SUP], Vincenzo Cantaluppi[SUP] 4 5 [/SUP], Giuseppe Cappellano[SUP] 4 [/SUP], Federico Ceruti[SUP] 4 5 [/SUP], Annalisa Chiocchetti[SUP] 4 [/SUP], Elisa Clivati[SUP] 5 [/SUP], Mara Giordano[SUP] 4 5 [/SUP], Daria Cuneo[SUP] 4 5 [/SUP], Eleonora Gambaro[SUP] 4 5 [/SUP], Eleonora Gattoni[SUP] 5 [/SUP], Alberto Loro[SUP] 4 5 [/SUP], Marcello Manfredi[SUP] 4 [/SUP], Umberto Morosini[SUP] 4 [/SUP], Francesco Murano[SUP] 4 5 [/SUP], Elena Paracchini[SUP] 5 [/SUP], Giuseppe Patti[SUP] 4 5 [/SUP], David James Pinato[SUP] 4 6 [/SUP], Davide Raineri[SUP] 4 [/SUP], Roberta Rolla[SUP] 5 [/SUP], Pier Paolo Sainaghi[SUP] 4 5 [/SUP], Stefano Tricca[SUP] 4 [/SUP], Mario Pirisi[SUP] 4 5 [/SUP]



Affiliations

Abstract

Many coronavirus disease 2019 (Covid-19) survivors show symptoms months after acute illness. The aim of this work is to describe the clinical evolution of Covid-19, one year after discharge. We performed a prospective cohort study on 238 patients previously hospitalized for Covid-19 pneumonia in 2020 who already underwent clinical follow-up 4 months post-Covid-19. 200 consented to participate to a 12-months clinical assessment, including: pulmonary function tests with diffusing lung capacity for carbon monoxide (DLCO); post-traumatic stress (PTS) symptoms evaluation by the Impact of Event Scale (IES); motor function evaluation (by Short Physical Performance Battery and 2 min walking test); chest Computed Tomography (CT). After 366 [363-369] days, 79 patients (39.5%) reported at least one symptom. A DLCO < 80% was observed in 96 patients (49.0%). Severe DLCO impairment (< 60%) was reported in 20 patients (10.2%), related to extent of CT scan abnormalities. Some degree of motor impairment was observed in 25.8% of subjects. 37/200 patients (18.5%) showed moderate-to-severe PTS symptoms. In the time elapsed from 4 to 12 months after hospital discharge, motor function improves, while respiratory function does not, being accompanied by evidence of lung structural damage. Symptoms remain highly prevalent one year after acute illness.
 
Back
Top Bottom